Magnolia Medical Again Sues Kurin Over Sepsis IP
Magnolia Medical has accused Kurin of continuing to infringe patents covering its diagnostic tests for sepsis and other bloodstream infections after Kurin lost a jury trial in 2022 over a different...To view the full article, register now.
Already a subscriber? Click here to view full article